New injection has been 100% successful in preventing HIV. It could be a twice-yearly shot for PrEP (pre-exposure prophylaxis) rather than taking a daily PrEP pill and could be out next year.
It still needs a second Phase 3 trial, but the results from the first Phase 3 trial are seem amazing.
https://www.cnbc.com/2024/06/20/gilead-prep-lenacapavir-succeeds-in-phase-3-trial.html
Shoshana 🏳️⚧️ /
npub12j…qfk4a
2024-06-20 23:36:02
Author Public Key
npub12jmnqzyzeza7p0ezrh4fl3svum6lnckujaf6vfk9t2rhz6xx9r5qeqfk4aPublished at
2024-06-20 23:36:02Event JSON
{
"id": "3365c1a5c7716cec500ad49760e845ad4c5eba0cd793d61e00b39b00fa7e9373",
"pubkey": "54b7300882c8bbe0bf221dea9fc60ce6f5f9e2dc9753a626c55a877168c628e8",
"created_at": 1718926562,
"kind": 1,
"tags": [
[
"proxy",
"https://tech.lgbt/@LilahTovMoon/112651571201339353",
"web"
],
[
"proxy",
"https://tech.lgbt/users/LilahTovMoon/statuses/112651571201339353",
"activitypub"
],
[
"L",
"pink.momostr"
],
[
"l",
"pink.momostr.activitypub:https://tech.lgbt/users/LilahTovMoon/statuses/112651571201339353",
"pink.momostr"
]
],
"content": "New injection has been 100% successful in preventing HIV. It could be a twice-yearly shot for PrEP (pre-exposure prophylaxis) rather than taking a daily PrEP pill and could be out next year.\n\nIt still needs a second Phase 3 trial, but the results from the first Phase 3 trial are seem amazing.\n\nhttps://www.cnbc.com/2024/06/20/gilead-prep-lenacapavir-succeeds-in-phase-3-trial.html",
"sig": "b6f64da36ae5aa4ca26b36b22adc628c642d5bf1ba375a079be80f0d87190ba915a8f62601380e8194abcf048a54aef19c533e688c31dbf757c321152825a0cd"
}